Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography
PDF Containing the Upcoming Market Analysis of Deep Brain Stimulation Devices for Parkinson's Disease is available at: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1435
Geriatric Population Represents Key Target Market for DBS Devices
Rapidly growing geriatric population has led to the high prevalence of neurological disorders such as Alzheimer’s disease, Parkinson’s disease, dementia, and others. This is one of the key factors driving the growth of the global DBS devices market for Parkinson’s disease. Neurological disorders are one of the major causes of mortality and are responsible for around 12% of deaths every year across the globe. Parkinson’s disease is the most prevalent neurological disorder after Alzheimer’s disease.
Though drug therapy is termed as the most effective treatment option to control the initial stages of Parkinson’s disease, surgical treatment using DBS devices is effective in the later stages of the disease. Patients and physicians increasingly prefer minimally invasive procedures for the treatment of Parkinson’s disease. The availability of technologically advanced DBS devices, coupled with favorable reimbursement scenario has led to the increased acceptance of DBS devices worldwide.
However, the risks associated with deep brain stimulation procedures might play spoilsport in the growth of the market. The implementation of certain government policies such as the Affordable Care Act in the U.S. would negatively impact the market’s growth during the forecast period. “The presence of a large patient pool across the emerging economies is expected to create new growth opportunities for the market,” a TMR analyst states.
Progressive Increase in New Cases of Parkinson’s Disease Puts New Opportunities in Focus
Among the key regions in the global DBS devices market for Parkinson’s disease, North America has been a major market owing to the growing prevalence of the disease. According to the Parkinson’s Disease Foundation, about 10 mn people worldwide suffer from this condition and over 1 mn of these patients are in the U.S. Around 60,000 new cases of Parkinson’s disease are diagnosed every year in the region. Furthermore, the growing awareness of the disease has propelled the growth of the regional DBS devices market.
Read Current Market Status of Deep Brain Stimulation Devices for Parkinson's Disease at: http://www.transparencymarketresearch.com/deep-brain-stimulator-market.html
The global deep brain stimulation devices market for Parkinson’s disease is projected to expand at a CAGR of 11% during the period from 2013 to 2019. The market stood at a valuation of US$4.5 bn in 2012 and is anticipated to be worth US$9.4 bn by the end of 2020.
Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comparative Analysis: Global Deep Brain Stimulation Devices Market for Parkinson’s Disease, by Geography here
News-ID: 429423 • Views: 327
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment
More Releases for Parkinson
QualitySolicitors Parkinson Wright invest in the future
QualitySolicitors Parkinson Wright has selected Liberate from Linetime as its business-wide legal services software platform. The Worcestershire based practice, with over 100 staff, operate from 4 offices and have a highly regarded reputation for their services including residential property, private client, family, dispute resolution and commercial. The firm also has its own estate agency. The firm recognised that to continue delivering high quality services to its clients it needed to provide
Wolff Parkinson White syndrome Market found Future opportunities of 2023
The Analysis presents the study of Global Wolff Parkinson White syndrome Market facilitating the regional and country wise analysis covering the strategic analysis of each market player and the market share they hold Wolff Parkinson White Syndrome Market Information: By Types (Type A, Type B) By Diagnosis (Electrocardiogram (ECG), Electrophysiological Testing, Others) By Treatment (Drugs (Anti-Arrhythmic, Beta-Blockers, Others), Cardioversion, Radiofrequency Catheter Ablation, Surgery, Artificial Pacemaker, Others) By End Users - Global
Global Belt Screen Changers Market 2017-2022 Nordson, Maag, JC Times, Parkinson, …
Belt Screen Changers Market Research Report A market study ” Global Belt Screen Changers Market ” examines the performance of the Belt Screen Changers market Size 2017. It encloses an in-depth Research of the Belt Screen Changers market state and the competitive landscape globally. This report analyzes the potential of Belt Screen Changers market in the present and the future prospects from various angles in detail. Request For Sample Report: http://bit.ly/2vgdMpD The
PARKINSON RESEARCH FOUNDATION’S (PRF) WESTERN CARIBBEAN FOURTH EDUCATIONAL CRU …
The Parkinson Research Foundation (PRF), a non-profit organization with a dedicated patient education program, will return to the Western Caribbean for its fourth educational cruise. PRF developed its educational cruise program to give Parkinson patients, caregivers family and loved ones unrivaled access to experts in the movement-disorder field. After visiting the Bahamas and Alaska on the first two respective PRF cruises, PRF’s ventured to the Western Caribbean on its most
PARKINSON RESEARCH FOUNDATION (PRF) Develops New Patient Outreach Program
One of the principal missions of the Parkinson Research Foundation (PRF) that distinguishes it from other Parkinson organizations is PRF’s focus on patient education; specifically education that enables Parkinson patients and their caregivers to live fuller and more comfortable lives with Parkinson's disease. The Foundation’s educational events, including educational cruises, gather leading Parkinson experts, therapists and nutritionists from across the country to offer life-changing tools and knowledge for individuals affected
Parkinson`s Disease:New Hope Educational Conference
PARKINSON’S DISEASE: NEW HOPE EDUCATIONAL CONFERENCE Become knowledgeable about the advancements in surgery The Parkinson Research Foundation is proud to announce that Dr. James Schumacher will be speaking about advances in surgery at our fourth annual New Hope for Parkinson’s conference on November 1st in Boca Raton. Dr. Schumacher is an internationally known expert in the field of neurosurgical treatment of Parkinson’s disease and movement disorders. He has an extensive background and